Deletion of the MBII-85 snoRNA Gene Cluster in Mice Results in Postnatal Growth Retardation by Skryabin, Boris V et al.
Deletion of the MBII-85 snoRNA
Gene Cluster in Mice
Results in Postnatal Growth Retardation
Boris V. Skryabin, Leonid V. Gubar, Birte Seeger, Jana Pfeiffer, Sergej Handel, Thomas Robeck, Elena Karpova
¤,
Timofey S. Rozhdestvensky, Ju ¨rgen Brosius
*
Institute of Experimental Pathology (ZMBE), University of Mu ¨nster, Mu ¨nster, Germany
Prader-Willi syndrome (PWS [MIM 176270]) is a neurogenetic disorder characterized by decreased fetal activity,
muscular hypotonia, failure to thrive, short stature, obesity, mental retardation, and hypogonadotropic hypogonad-
ism. It is caused by the loss of function of one or more imprinted, paternally expressed genes on the proximal long arm
of chromosome 15. Several potential PWS mouse models involving the orthologous region on chromosome 7C exist.
Based on the analysis of deletions in the mouse and gene expression in PWS patients with chromosomal
translocations, a critical region (PWScr) for neonatal lethality, failure to thrive, and growth retardation was narrowed to
the locus containing a cluster of neuronally expressed MBII-85 small nucleolar RNA (snoRNA) genes. Here, we report the
deletion of PWScr. Mice carrying the maternally inherited allele (PWScr
m /pþ) are indistinguishable from wild-type
littermates. All those with the paternally inherited allele (PWScr
mþ/p ) consistently display postnatal growth
retardation, with about 15% postnatal lethality in C57BL/6, but not FVB/N crosses. This is the first example in a
multicellular organism of genetic deletion of a C/D box snoRNA gene resulting in a pronounced phenotype.
Citation: Skryabin BV, Gubar LV, Seeger B, Pfeiffer J, Handel S, et al. (2007) Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation. PLoS
Genet 3(12): e235. doi:10.1371/journal.pgen.0030235
Introduction
The human genetic locus 15q11-q13 is subject to genomic
imprinting that is controlled by a bipartite imprinting center
(IC) [1]. Imprinting defects or chromosomal rearrangements/
deletions within this locus (Figure 1) are responsible for the
development of two clinical disorders—Angelman (AS) and
Prader-Willi (PWS) syndromes. AS (MIM 105830) is a complex
neurogenetic disorder characterized by mental retardation,
severe limitations in speech and language and abnormal
behavior, and results from loss of maternal expression of the
Ube3A gene [2]. PWS (MIM 176270) is a complex neurogenetic
disorder with a population prevalence of 1 in 10 000 to 50 000
[3–5] that is characterized by decreased fetal activity,
muscular hypotonia, failure to thrive, short stature, obesity,
mental retardation, and hypogonadotropic hypogonadism,
for review, see [2,6]. PWS results from lack of paternal
expression of one or several imprinted genes within the PWS/
AS locus. Several paternally expressed protein-coding genes
map to this locus, including NECDIN (NDN), MAGEL2,
MKRN3, and the bi-cistronic SNURF-SNRPN (Figure 1B).
There are also numerous paternally expressed C/D box
snoRNA genes located downstream from the SNURF-SNRPN
gene. Most of them are organized into two main clusters of
HBII-85 and HBII-52 snoRNAs, containing 29 and 47 copies,
respectively. Other snoRNAs are present as single (HBII-436,
HBII-13 and HBII-437) or double copy (HBII-438a/438b) genes
(Figure 1B). Most, if not all, snoRNAs are processed from a
long, non-protein-coding RNA (npcRNA) transcript desig-
nated U-UBE3A-ATS in human and Lncat (large paternal non-
protein-coding RNA, encompassing Snurf-Snrpn and Ipw
exons together with the Ube3a antisense transcript) in mouse
[7–9]. U-UBE3A-ATS extends ;450 kb from the untranslated
U exons upstream of the small nuclear ribonucleoprotein N
(SNURF/SNRPN) gene to the UBE3A gene (Figure 1B).
In mouse the syntenic PWS/AS locus is located on
chromosome 7C and contains all the aforementioned protein
coding and non-protein-coding gene orthologs, except for
the presence of protein-coding gene Frat 3 and absence of
HBII-437 and HBII-438a/438b snoRNA genes (Figure 1C).
Several mouse models for PWS have already been generated
(Figure 1D). They can be divided into 3 groups: 1) transgenic
mouse lines with disruptions of the PWS/AS locus; 2) mice
with targeted elimination of the imprinting center (IC)
controlling transcription of PWS genes, or targeted elimi-
nation of individual, single genes from the PWS locus; and 3)
mice with uniparental paternal disomy (UPD) [10,11].
In all existing PWS mouse models (Figure 1D) that involve
large deletions comprising several paternally expressed,
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early postnatal lethality) were observed [10,12–15]. Targeting
of the single Mkrn3 and Snrpn genes, or some of the Ipw exons
together with the MBII-52 snoRNA genes cluster [13,15–17] or
deletion of an analogous region in human [18] all produced
no PWS-like phenotypes. Elimination of the Magel 2 gene
caused altered behavioral rhythmicity (Figure 1D8) [19].
However this gene is unlikely to be a main ‘‘PWS player’’
[20]. Currently, only elimination of the single Necdin gene
leads to the development of early postnatal lethality and
neurological abnormalities resembling the PWS, although the
phenotypic effect depends on the targeted region and genetic
background of the mice, some of which had no apparent
phenotype [21–23]. The PWS critical region (PWScr) was
narrowed to the locus containing the MBII-85 small nucleolar
RNA (snoRNA) gene cluster based on existing mouse models
[16] and gene expression analysis in PWS patients with
chromosomal translocations [18,24,25]. These studies indicate
that SNURF/SNRPN, MKRN3, NECDIN and MAGEL2 genes
are unlikely to play a primary role in the pathogenesis of
PWS. However, the question of their possible functional
contribution to more severe phenotypic expression seen in
typical PWS patients remains open [16,18,24]. We have
applied the ‘‘chromosome engineering’’ technique [26] to
delete the PWScr in mice. When the deleted allele is inherited
maternally (PWScr
m /pþ), no phenotypic abnormalities are
visible. When it is inherited paternally (PWScr
mþ/p ), we
consistently observe postnatal growth retardation in mice
and less than 15 percent postnatal lethality in 129SV x
C57BL/6 genetic crosses.
Results/Discussion
To test the hypothesis that the PWScr is the most probable
candidate region for neonatal lethality, failure to thrive and
postnatal growth retardation, we devised the following
strategy for producing PWScr
mþ/p  mice (Figure 1E and 1F).
Hypoxanthine-guanine phosphoribosyltransferase (HPRT)-
deﬁcient ES cells, AB2.2, were modiﬁed through homologous
recombination (HR) using targeting constructs 59HPRT/
PWScr_targ and 39HPRT/PWScr_targ to place loxP sites
proximaltothe59ﬂankingregionoftheMBII-85snoRNAgene
cluster and distal to the Ipw exon C, respectively (Figure 1E).
Deletion of the PWScr harboring the entire cluster of MBII-85
snoRNA genes together with Ipw exons A-C was accomplished
by expressing CRE recombinase in ES-targeted cells (Figures
1F and 2A) and injecting these into blastocysts. We identiﬁed
two chimaeras derived from one of the PWScr-deleted ES
clones with successful germ-line transmission. Deletion of the
PWScr allele was conﬁrmed several ways: 1) Resistance of ES
cells to HAT media requires a functional HPRT gene.
Restoring the intact HPRT gene through deletion of the
PWScr leads to resistance of ES cells to HAT media. 2)
Southern blot analysis of all HAT-resistant ES colonies (data
not shown), as well as all PWScr-deleted mice, using 59HR and
39HR probes (Figure 2A and 2B), revealed identical bands
correspondingtothecorrectlydeletedPWScrallele(19998bp).
3) We PCR ampliﬁed and sequenced ﬂanking regions of the
PWScrlocustogetherwiththeinsertedHPRTgene(Figures1G,
2C, and S1) using PCR primers MB85seqD1 and MB85seqR1
(Table S1), and conﬁrmed the deleted PWScr allele as well.
PWScr
mþ/p  pups born from chimaeras were signiﬁcantly
smaller than their wild-type siblings, such that on postnatal
day 10, the PWScr
mþ/p  individuals (Figure 3) could be reliably
predicted prior to DNA analysis. We monitored the weights of
all mice over several weeks after continuous breeding and
found that only the PWScr
mþ/p and PWScr
m /p mice displayed
postnatal growth retardation compared to the PWScr
mþ/pþ
siblings. Statistical analyses were performed on mice sepa-
rated by genotype, genetic background and gender (Figures
4A–4D and S2), as well as separately for litters (data provided
upon request). Postnatal growth retardation in PWScr
mþ/p 
mice was observed, thus far, over six generations, independent
of genetic background [e.g., 129SV x C57BL/6 (.85% C57BL/6
genetic background contribution, Figure 4A and 4B), 129SV x
C57BL/6 x FVB/N (;50% FVB/N contribution, Figure S2A and
S2B), and 129SV x C57BL/6 x BALB/c (;50% BALB/c
contribution, Figure S2C and S2D)]. Differences in growth
dynamics between PWScr
mþ/pþ and PWScr
m /p  or PWScr
mþ/p 
mice continued to be statistically signiﬁcant into adulthood
(up to 1 year in BALB/c crosses) (Figure 4A, 4B, and S2).
Moreover, not a single case of obesity was detected. Interest-
ingly, when growth dynamics for mice were analyzed by
gender, deﬁciencies in the PWScr
mþ/p  or PWScr
m /p  female
mice tended to be less pronounced than those in the male
deletion mice (Figure 4A, 4B, S2C, and S2D). This observation
is well correlated with a statistical analysis of PWS patients
indicating that the degree of short stature is more prominent
in males than in females, irrespective of ethnic groups (genetic
background) [27]. Furthermore, mice with the maternally
transmitted PWScr-deleted allele were indistinguishable from
their wild type littermates (Figure 4C). In addition, males
(59HPRT) derived from 59HPRT/PWScr_targ-targeted ES cells
were crossed with C57BL/6 females. As expected, we did not
observe growth retardation in the 59HPRT
m /pþmice (p¼0.275)
(Figure 4D).
Notably, the observed postnatal growth retardation phe-
notype became apparent during the ﬁrst week of life starting
from postnatal day 5 in males and 6 in females (Figure 4A and
4B; Table S2), while there were no growth differences at early
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Author Summary
Prader-Willi syndrome, or PWS, is a complex neurogenetic disorder
and the most common genetic cause of life-threatening childhood
obesity. Newborns have poor muscle tone, making suckling difficult,
which leads to poor weight gain. After infancy, they experience
extreme hunger, leading to obesity. Other symptoms include short
stature, mental retardation, and often infertility. In PWS patients, a
complex set of genes on the paternal chromosome 15 (in the PWS
region) is missing or unexpressed. In an attempt to understand this
disorder, various protein-coding genes in this region have been
deleted in mice, but none of the resulting phenotypes consistently
correlated with the human disease. This region also contains a
cluster of genes that encode functional non-protein-coding RNAs.
We deleted specifically the MBII-85 small nucleolar RNA (snoRNA)
gene cluster on the parental mouse chromosome, which did not
affect expression of any of the other snoRNA or protein-coding
genes in the PWS region. These mice consistently displayed
postnatal growth retardation starting from day 5 to 6, low postnatal
lethality only in certain genetic backgrounds (,15%), and no
adolescent obesity. Thus, this mouse model, with the deletion of a
small, brain-specific non-protein-coding RNA, should prove useful
for teasing out the various molecular pathologies of PWS.Figure 1. Genome Organization of the PWS/AS Locus in Man and Mouse
(A) Structure of human chromosome 15.
(B) Schematic representation of the human 15q11-q13 region (not drawn to scale). The centromeric (cen) and telomeric (tel) positions are labeled. PWS
protein coding genes and snoRNA genes are marked as boxes and ovals, respectively. Paternally, maternally, and biparentally expressed genes are
labeled blue, red, and white, respectively. IPW exons of the paternally expressed, imprinted U-UBE3A-AS transcript are indicated by green bars and a
blue arrow, respectively. The imprinting center (IC) is indicated with a small circle. The snoRNA genes: HBII-436, HBII-13, HBII-437, HBII-438A, HBII-85. HBII-
52 and HBII-438B are labeled as 436, 13, 437, 438A, 85, 52 and 438B, accordingly.
(C) Corresponding mouse syntenic chromosome 7C region. The paternally expressed Lncat transcript is indicated by a blue arrow.
(D) Deletions in the PWS/AS region. (1) Insertion of the Epstein–Barr virus Latent Membrane Protein 2A, (LMP2A) transgene into the PWS/AS locus
resulted in deletion of approximately 4 megabases between the Mlsn1 and Gas2 genes [12,29]. Depending on the parental origin it causes PWS or AS
symptoms in mice. (2) The 42 kb Snrpn promoter PWS-IC deletion resulted in loss of imprinting and a PWS-like phenotype in mice [13]; analogous
deletion of the PWS-IC and Snrpn gene up to exon 7 results in a paternal to maternal imprint switch and leads to PWS [40]. (3) Paternal Snrpn exon 2
deletion [14] produced no abnormal phenotype. (4) Mice with a deletion of 1kb (exons 5–7) of the Snrpn gene are phenotypically normal [13]. (5)
Paternal deletion from Snrpn to Ube3a resulted in a PWS-like phenotype in mice [14]. (6) Deletion affecting npc Ipw exons and MBII-52 snoRNA gene
cluster after paternal inheritance produced no PWS-like phenotype [15]. (7) Targeting of the Necdin gene produced either a PWS-like phenotype [21,23]
or no obvious phenotype [22]. The discrepancies were explained by different strategies in Necdin targeting and different mouse genetic backgrounds
[15]. (8) Inactivation of the Magel2 gene produced altered behavioral rhythmicity [19]. (9) Deletion of the Mkrn3 (Zfp127) gene had no apparent
phenotypic effect [15]. (10) PWS critical region (PWScr). It has been proposed that deletion of this region should play a major role in the development of
PWS [16,24]. Paternal deletion of PWScr causes growth retardation in mice (this study).
(E) Locus containing the cluster of MBII-85 snoRNA genes and Ipw exons, and its deletion targeting strategy using ‘‘chromosome engineering’’ [26].
Filled boxes represent 59HR and 39HR DNA probes (labeled green and purple respectively). Targeting constructs 59HPRT/PWScr_targ and 39HPRT/
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agreement with the absence of early postnatal growth
retardation, no weight differences were observed during
embryonal development at E12.5, E15.5 and E18.5, or in late
gestation (E15.5 and E18.5) placentas (Figure 4E, and data not
shown). Hence, one possible explanation for our observations
might be poor breast-feeding in PWScr
mþ/p pups as is the case
with postnatal PWS patients. Insufﬁcient milk intake result-
ing in growth retardation is consistent with the Holland
hypothesis and observations in TgPWS mice (transgenic
deletion PWS mouse model; Figure 1D1) suggesting, that
the main basis of the PWS syndrome is not obesity and
uncontrollable craving but early postnatal starvation [28,29].
The PWScr
mþ/p  mice exhibit postnatal growth retardation,
but contrary to early predictions [16] postnatal lethality was
observed in only 15 percent of the cases in 129SV x C57BL/6
genetic crosses (Figure 4F). On the other hand, we did not
observe postnatal lethality in the FVB/N crosses. PWScr
mþ/p 
mice were dying from postnatal days 1 to 22. The surviving
PWScr
mþ/p  and PWScr
m /p  mice are alive and apparently well
for at least 1 year. In future experiments, it would be
interesting to test the possible role of MBII-13 and MBII-436
snoRNAs and/or the genomic region between the Snrpn and
MBII-85 genes for their contributions to more severe
phenotypes with higher rates of postnatal lethality. In
addition, our PWScr
mþ/p  mouse model is in good agreement
with two recently identiﬁed patients with a balanced
chromosomal translocation involving SNRPN [24,30]. Both
patients lack HBII-85 expression and exhibit a mild PWS
phenotype, (e.g., they did not require gavage feeding, but
were growth retarded.)
PWS is also characterized by hypogonadotropic hypogo-
nadism and infertility in patients [6]. We studied the fertility
of the PWScr
mþ/p  and PWScr
m /pþ mice and observed that
PWScr
mþ/p  males and females transmitted the PWScr deleted
allele to offspring. To further extend our observations, we
established 10 breeding pairs from each of the PWScr
mþ/p and
PWScr
m /pþ males with 80 wild-type females. All matings
resulted in pregnancies leading to successful live births with
litter sizes around eight (7.93 6 0.46 for PWScr
mþ/p  and 8.33
6 0.48 for PWScr
m /pþ males), and always included wild-type
mice and mice carrying the PWScr-deleted allele in a ratio of
1:1 (4.17 6 0.34 : 3.66 6 0.38 for PWScr
mþ/p  and 4.00 6 0.54 :
4.17 6 0.53 for PWScr
m /pþ; Table S3). Thus, male mice
containing the PWScr-deleted allele inherited maternally or
paternally, are transmitting this allele in a Mendelian fashion.
The PWS locus includes several paternally expressed,
protein coding genes, including Necdin, Magel2, Mkrn3, Frat3,
and the bi-cistronic Snurf-Snrpn. To examine whether the
deletion of the paternal PWScr from mouse chromosome 7C
perturbed the expression of the aforementioned imprinted
genes, we analyzed their expression levels in our mice by RT-
PCR and real-time PCR. We failed to detect any signiﬁcant
differences in the expression levels of the investigated genes
inPWScr
mþ/p micecomparedtocontrollittermatesPWScr
mþ/pþ
(Figure 5A; Table 1). In addition, the controversial data
concerning the involvement of Necdin in the PWS phenotype
[21–23] prompted us to also examine its expression in more
detail by Northern blot hybridization (Figure 5B). Consistent
with the RT-PCR and real-time PCR results, there were no
differences in the levels of Necdin mRNA in brains of the
PWScr
mþ/p , PWScr
m /pþ or control PWScr
mþ/pþ, 59HPRT
mþ/pþ
and 39HPRT
mþ/pþ mice (Figure 5B; Table 1 and data not
shown).
We also examined the levels of the maternally expressed,
imprinted Ube3a and Atp10a protein coding genes, located at
the end of the PWS locus and involved in the development of
AS [2] (Figure 1B and 1C). The RT-PCR (Figure 5A), real-time
PCR (Table 1), and Northern blot hybridization (Figure 5C
and 5D) analyses revealed similar expression levels of both
genes in brains of PWScr
mþ/p  and PWScr
m /pþ, as well as in
control mice.
The mouse PWS locus on chromosome 7C also contains
numerous neuronal, paternally expressed C/D box snoRNA
genes, including two single copies of MBII-436 and MBII-13,
and two multiple copy clusters, MBII-85 and MBII-52 [7,31].
Vertebrate snoRNAs are embedded in introns of protein
coding genes, which are posttranscriptionally processed to
yield mature mRNA and snoRNA. Occasionally the spliced
exons are devoid of open reading frames, as if the sole
function of the transcript is the expression of the snoRNA
[32]. This is apparently the case for most, if not all, snoRNAs
from the PWS locus that are co-transcribed with the large
paternally expressed polycistronic Lncat npcRNA [7–9]. The
Lncat transcript is complex and generates, by alternative
splicing and other processing events, numerous RNA prod-
ucts (e.g., those represented by expressed sequenced tags
(ESTs) and mature snoRNAs). The corresponding Ipw exons
are a subset of Lncat-derived ESTs and map to the MBII-85
and MBII-52 snoRNA clusters that are interspersed with
repeated exons A1/A2 and G1/G2, respectively [31,33]. The
Ipw exons B, C, H, E, F map between both clusters. Northern
blot analyses of RNA samples extracted from brains of
PWScr
mþ/p  mice revealed the complete absence of MBII-85
snoRNA while expression of all other snoRNA genes in the
PWS locus were unaffected (Figure 6A).
We then analyzed the expression of the Ipw exons using
Northern blot hybridization with a cDNA probe containing
the F and G exons, and found it to be slightly decreased in
PWScr
mþ/p  mice (Figure 6B). However, expression of MBII-52
snoRNA was not altered, presumably because the primary
Lncat transcript can undergo different processing pathways
to yield mature MBII-52 snoRNA (Figure 7). Recently it was
reported that lack of HBII-52 snoRNA genes together with
most of the IPW exons did not result in a PWS phenotype in
either human individuals [18] or in a mouse model [15,16].
Therefore, it is less likely that deletion of alternatively spliced
Ipw exons A1/A2, B and C are responsible for the phenotype
we obtained here, although we cannot completely exclude the
possibility that lack of those exons in a long npcRNA can
contribute to it. In future experiments, we will address the
question, whether expression of MBII-85 snoRNA in a
PWScr_targ are indicated. Open boxes correspond to the Thymidine kinase gene (TK), Neomycin resistance gene (Neo), Puromycin resistance gene (Puro),
as well as the 59 and 39 parts of the Hypoxanthine Phosphoribosyl Transferase gene (HPRT). LoxP sites are indicated by arrows.
(F) Structure of the PWScr after two consecutive HR events, and CRE recombinase-induced deletion.
(G) Sequencing of integration sites after HR and deletion of the PWScr confirmed the anticipated deletion at the nucleotide level. Extended sequences
(Genbank accession number EU233428) of regions flanking the HPRT cassette insertion are presented in Figure S1.
doi:10.1371/journal.pgen.0030235.g001
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phenotype.
Lack of MBII-85 snoRNA expression in PWScr
mþ/p  com-
pared to PWScr
m /pþ mice, along with the unaltered expres-
sion of paternally and maternally expressed genes from the
PWS/AS locus in both heterozygous mice, indicates that
deletion of PWScr does not affect imprinting of neighboring
genes. Moreover, patients with translocations leading to a
similar deletion encompassing the genes encoding HBII-85
and HBII-438A snoRNA exhibit normal biparental methyl-
Figure 2. Analysis of Mice with the PWScr Deletion
(A) Schematic representation of 1. wild-type and 2. PWScr targeted alleles. DNA fragments are labeled according to Figure 1E and 1F. EcoRV (RV)
restriction endonuclease sites are designated by vertical arrows. Sizes of diagnostic restriction fragments are indicated. The positions of PCR primers
MB85deld1 and MB85delr1 are shown.
(B) Southern blot analysis. EcoRV digested DNA samples of individual mice (genotype indicated on top) were hybridized with 59HR and 39HR probes.
Bands representing the wild-type alleles (12987 bp for 59HR and 9063 bp for 39HR) and the PWScr-deleted allele (19998 bp) are indicated by arrows. Size
markers (14140, 8453, 7242, 6369, and 5687 bp) are represented by horizontal bars between the two blots.
(C) Genotyping by PCR analysis using primers MB85deld1/MB85delr1 (positions are shown in A). Deletion of PWScr results in a PCR product of 1665 bp.
Genotypes of mice are indicated.
doi:10.1371/journal.pgen.0030235.g002
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Elimination of MBII-85 snoRNA Gene Cluster in Miceation patterns [24,30]. Thus, absence of MBII-85 snoRNA is
the most likely cause for the phenotype observed in
PWScr
mþ/p  and PWScr
m /p  mice (Figure 6A).
In Eukarya, most C/D box npcRNAs guide site-speciﬁc 29-
O-methylation in rRNAs and small nuclear RNAs (snRNAs) by
complementarity to deﬁned sites within these RNA targets
[34]. However, most if not all C/D box small npcRNAs that
map to the PWS locus, including MBII-85 and MBII-52
snoRNAs, lack signiﬁcant complementarities to any rRNA or
snRNA targets [7,31]. Although a major role for MBII-52 in
the etiology of the PWS can be excluded, cell culture
experiments have suggested that MBII-52 snoRNA might play
a role in A to I editing and/or alternative splicing of the 5HT-
2c serotonin receptor pre-mRNA [35,36]. In spite of these
discrepancies, one might still be tempted to propose that
MBII-85 snoRNA interacts (by complementarity) with a yet
unidentiﬁed RNA target. However, other less orthodox
functions for MBII-85 snoRNA and its role in postnatal
growth retardation must also be seriously entertained. In any
event, MBII-85 is the ﬁrst example of a C/D box snoRNA gene,
whose deletion results in an obvious phenotypic change in a
multicellular organism. Future experiments might reveal
additional, less obvious defects and deﬁciencies in PWScr
mþ/p 
mice. Our mouse model will serve as an important tool for
further investigations of the molecular pathogenesis of PWS
in man.
Materials and Methods
Targeting vectors. For construction of the 59HPRT/PWScr_targ
and 39HPRT/PWScr_targ targeting vectors, we isolated clones
RPCIP711K19517Q6 and RPCIP711J18414Q6, respectively, from the
RPCI21 mouse PAC library (RZPD German Resource Center for
Genome Investigation) using the MBII-85 oligonucleotide (Table S1).
The 59HPRT/PWScr_targ construct was generated using the 59
ﬂanking region of the MBII-85 gene cluster as a template for PCR-
ampliﬁcation of 1075 bp and 7387 bp DNA fragments with primer
pairs 59FLAdir/59FLArev and 59FLBdir/59FLBrev, respectively. The
PCR fragments were used as homologous arms in the targeting vector.
The cassette containing the 59 portion of the HPRT gene, the loxP
site, and the neomycin resistance gene was subcloned from a k phage
vector kindly provided by A. Bradley (Baylor College of Medicine,
Houston, USA). The thymidine kinase (TK) gene was placed outside of
the homologous arm (Figure 1E).
The 39HPRT/PWScr_targ construct was cloned in a similar way.
The 39 ﬂanking region of the MBII-85 gene cluster was used as a
template to PCR-amplify 1098 bp and 6720 bp DNA fragments using
primer pairs 39FLBdirN/39FLBrev and 39FLAdir/39FLArev, respec-
tively. The insertion cassette, containing the 39 portion of the HPRT
gene, the loxP site, and the puromycin resistance gene was subcloned
from the k phage vector kindly provided by A. Bradley. The TK gene
was placed outside of the homologous arm.
Cloning of 59HR and 39HR probes for DNA blot hybridization. The
59 HR probe for Southern blot hybridization was generated by using
the PAC DNA containing the 59 region of the MBII-85 gene cluster in
two PCR reactions with oligonucleotide pairs 59PRAdir/59PRArev and
59PRBdir/59PRBrev, and ligating and cloning the resulting PCR
products into the pSL300 vector [37]. The 39 HR probe was cloned
in a similar fashion. PCR products were obtained with oligonucleo-
tide pairs 39PRAdir/39PRArev and 39PRBdir/39PRBrev (Table S1).
ES cell transfection, selection of targeted clones and blastocyst
injections. HPRT-deﬁcient embryonic stem cells AB2.2 (from A.
Bradley), passage 17, were expanded in HEPES-buffered, Dulbecco’s
modiﬁed Eagle’s medium supplemented with 15% fetal bovine serum
(HyClone), nonessential amino acids, L-glutamine, b-mercaptoetha-
nol, 1000 U/ml recombinant LIF (Chemicon) and antibiotics
(penicillin 100 U/ml and streptomycin 100 lg/ml) on a c-irradiated
monolayer of SNL6.7 cells (from A. Bradley) or mouse primary
ﬁbroblasts. For electroporation, 2310
7 ES cells were resuspended in
20 mM HEPES pH 7.4, 173 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4,6
mM dextrose, and 0.1 mM b-mercaptoethanol [38]. The NotI
linearized replacement targeting vectors 59HPRT/PWScr_targ,
39HPRT/PWScr_targ, and intact CRE expressing cassette pOG231
(55 lg DNA of each) were electroporated at 25 lF and 400V (Gene
Pulser; Bio-Rad). After electroporation, cells were plated onto 100
mm culture dishes containing a c-irradiated monolayer of primary,
G-418-resistant, or SNL6.7 (G-418, puromycin- and HAT-resistant)
ﬁbroblast feeder cells. Thirty-eight hours later, 350 lg/ml G418
(Invitrogen) and 0.2 lM2 9-deoxy-29-ﬂuoro-b-D-arabinofuranosyl-5-
iodouracil (FIAU) (Moravek Biochemicals and Radiochemicals, USA)
or 1.0 - 0.5 lg/ml puromycin (Sigma) and 0.2 lM FIAU, or HAT
(Sigma) were added to the culture medium. The medium was replaced
every day and colonies were picked and analyzed eight days after
plating. 59HPRT loxP-targeted ES cells were analyzed using oligonu-
cleotide pairs 85–59screen2d/85–59screen2r and 85–59screen3d/85–
59screen3r for a nested PCR approach. For analysis of 39HPRT loxP-
targeted cells we employed the 85–39screen1d/85–39screen1r and 85–
39screen2d/85–39screen2r nested PCR primer pair combinations.
DNA blot analysis was performed as described [39]. Membranes were
hybridized with
32p labeled 59HR and 39HR probes (Figure 2A).
Several independent ES clones containing the CRE-mediated PWScr-
deletion were injected into 3.5-day-old B6D2F1 (C57BL/6 x DBA)
blastocysts, and the resulting embryos were transferred to CD-1 foster
mice. Chimeras were identiﬁed by their agouti coat color.
PCR ampliﬁcation and sequencing ﬂanking regions of PWScr. The
5.7 kb DNA fragment containing ﬂanking regions of PWScr together
with the inserted HPRT gene was ampliﬁed and sequenced using PCR
primers MB85seqD1 and MB85seqR1. Sequencing reactions were
performed using the BigDye terminator cycle sequencing reaction kit
(PE Applied Biosystems) and resolved on an ABI Prism 3100 (Perkin
Elmer) capillary sequencing machine.
PWScr mice genotyping. To genotype mice we performed PCR
analysis of genomic DNA from tail biopsies using the primer pair
MB85deld1/MB85delr1 (Figure 2A and 2C; Table S1). PCR cycling was
done at 93 8C – 2 min; 7 cycles (93 8C – 40 sec, 70
oC – 20 sec, touch
down 1 8C, extension 67
oC – 1 min 40 sec); 35 cycles (93 8C – 40 sec,
55
oC – 20 sec, 67
oC – 1 min 40 sec). The ﬁnal extension was
performed at 67 8C for 5 min.
RT PCR and Northern blot analysis. Total RNA was isolated from
mouse brains using TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions. RNA samples, 20 lg each, were treated
with RNase-free DNase I (Roche). First strand cDNA synthesis was
performed using Transcriptor reverse transcriptase (Roche) and
hexamer oligonucleotides, followed by PCR ampliﬁcation with gene
speciﬁc oligonucleotides (Table S1). The cDNA probes for necdin,
Ube3A, Atp10a mRNAs, and Ipw exons were PCR ampliﬁed, cloned in
the pCRII vector (Invitrogen), and subsequently sequenced using gene
speciﬁc oligonucleotides (Table S1). Approximately 20 lg of total
RNA was denatured, fractionated on 1.2% agarose formaldehyde gels,
and transferred to GeneScreen nylon membranes (NEN DuPont).
Figure 3. Growth Differences among PWScr
mþ/p  and PWScr
mþ/pþ
Siblings
Representative pair of mice from the same litter at postnatal day 10
(129SV x C57BL/6 genetic crosses).
doi:10.1371/journal.pgen.0030235.g003
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32P-labeled cDNA probes. North-
ern blot analysis of snoRNAs was performed with speciﬁc oligonu-
cleotides (Table S1) as described [31].
Mice. A PWScr-deﬁcient mouse line was established by breeding
male chimeras nos. 2 and 5 from one mutant ES cell line with female
C57BL/6 mice to produce heterozygous mice. Subsequently, hetero-
zygous mice were interbred or bred to C57BL/6 mice. All breeding
occurred at the ZMBE animal facility of the University Clinics,
Mu ¨nster in a controlled (21 8C, 30–50% humidity) room with a 12:12
hour light-dark cycle, and mice were housed under non-enriched,
standard conditions in individually ventilated (36 (l) x 20 (w) x 20 (h)
cm) cages for up to ﬁve littermates. Pups were weaned 19 – 23 days
after birth and females were kept separately from males.
Statistical analysis. Statistical analysis was performed using the
StatView software package. Body weight was analyzed using Student’s
t-test, or ANOVA for each day of postnatal age. Weights of placentas
and embryos were analyzed using Mann-Whitney nonparametric
statistics. Postnatal lethality was analyzed with the chi-square test.
Figure 4. Growth Retardation and Postnatal Lethality in PWScr
mþ/p  Mice (129SV x C57BL/6 Genetic Background)
(A) Growth dynamics of 82 investigated male mice. The yellow line corresponds to weight gain of 34 mice with the PWScr-deleted allele; black bars are
statistically significant intervals (confidence level 95%, p¼0.05). The black line corresponds to 48 wild-type males; black bars are statistically significant
intervals (p¼0.05).
(B) Growth dynamics of 82 investigated female mice. The yellow line corresponds to weight gain in 38 females with the PWScr-deleted allele; black bars
are statistically significant intervals (p¼0.05). The black line corresponds to 44 wild-type females; black bars are statistically significant intervals (p¼0.05).
(C) Growth dynamics of 40 female mice with the maternally transmitted PWScr-deleted allele. The red line corresponds to weight gain in 16 females
with the PWScr-deleted allele; green bars are statistically significant intervals (p¼0.05). The black line corresponds to 24 wild-type females.
(D) Growth comparison of 15-day-old control mice with wild-type mice. Mice, containing the 59HPRT/PWScr_targ cassette in the PWScr locus
(59HPRT
m /pþ; 6.89860.257 g), are represented by white bars, and wild-type mice (6.71160.129 g) by black bars (p¼0.2751).
(E) Embryo weights (E18.5) and the corresponding placenta weights (n¼15 for all groups). The weights of embryos and placentas from PWScr
mþ/pþand
PWScr
mþ/p  mice are indicated with black and yellow bars, respectively. Embryo weights E18.5 PWScr
mþ/pþ 1.29060.105 g (mean6SD), PWScr
mþ/p 
1.25360.151 g, (p¼0,934); placenta weights E18.5 PWScr
mþ/pþ 0.08660.012 g, PWScr
mþ/p  0.09460.021 g, (p¼0.290).
(F) Postnatal lethality of PWScr
mþ/p  (n¼64) and wild type PWScr
mþ/pþ (n¼57) mice in 129SV x C57BL/6 (.85% C57BL/6 contribution) genetic crossings
(p,0.02). White and black bars represent percentages of surviving and dead mice, respectively, after 90 days.
doi:10.1371/journal.pgen.0030235.g004
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Figure S1. Sequences at the Site Replacing the PWScr with the HPRT
Cassette
The primary sequence of the 59- (chr7:67,076,064) and 39-
(chr7:66,883,161) regions ﬂanking the inserted HPRT cassette
(Genbank accession number EU233428). The sequence of Ipw exon
H is underlined. The sequence positions correspond to the UCSC
Genome Browser (mouse, July 2007 assembly). The compiled deleted
region is estimated to span ;193 kb; however, because the gap size is
only estimated (;50 kb chr7:66,952,205–67,002,206), the region
deleted in our mouse model could span from 143 to  193 kb.
Found at doi:10.1371/journal.pgen.0030235.sg001 (82 KB PDF).
Figure S2. Growth Retardation in PWScr
mþ/p  Mice in FVB/N and
BALB/c Genetic Crosses
(A, B) Growth dynamics of mice in 126SV x C57BL/6 x FVB/N genetic
crosses (;50% FVB/N contribution) beginning at postnatal day 1.
Figure 5. mRNA Analysis of PWS and AS Imprinted Genes in PWScr-Deleted Mice
(A) RT-PCR analysis. Mouse genotypes are indicated. 59HPRT
þ/þ and 39HPRT
þ/þ correspond to homozygous 59HPRT/PWScr_targ or 39HPRT/PWScr_targ
targeted mice, respectively; size markers are given in bp at the left; the position of RT-PCR products corresponding to individual transcripts are marked
by arrows. Gapdh and b-Act transcripts were used as controls.
(B–D) Northern blot analyses of selected mRNAs from the PWS locus. Ethidium bromide-stained RNA gels (prior to blotting) are shown as RNA loading
controls. RNA size markers are as follows: 6000, 4000, 3000, 2000, 1500, 1000, 500, and 200 nt.
doi:10.1371/journal.pgen.0030235.g005
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Elimination of MBII-85 snoRNA Gene Cluster in Mice(A) Growth dynamics of 11 investigated males. The yellow line
corresponds to the weight gain of 8 PWScr
mþ/p  males. The black line
corresponds to the weight gain of 3 wild-type males.
(B) Growth dynamics of 21 investigated female mice. The yellow line
corresponds to the weight gain of 13 PWScr
mþ/p  females. The black
line corresponds to the weight gain of 8 wild-type females.
(C, D) Growth dynamics of mice in 126SV x C57BL/6 x BALB/c genetic
crosses (;50% BALB/c contribution) beginning at postnatal week 6.
(C) Growth dynamics of 100 analyzed male mice. The yellow line
corresponds to weight gain of 47 PWScr
mþ/p  males. The black line
corresponds to 53 PWScr
mþ/pþ males.
(D) Growth dynamics of 102 female mice. The yellow line corresponds
to the weight gain of 51 PWScr
mþ/p  females. The black line
corresponds to the weight gain of 51 PWScr
mþ/pþ females. In all cases,
black error bars exhibit statistically signiﬁcant intervals (conﬁdence
level 95%, p¼0.05).
Found at doi:10.1371/journal.pgen.0030235.sg002 (109 KB PDF).
Table S1. Sequences of Oligonucleotides Used in This Study
Found at doi:10.1371/journal.pgen.0030235.st001 (27 KB DOC).
Table S2. Statistical Analysis (ANOVA) of Early Postnatal Weight
Gain for PWScr
mþ/pþ and PWScr
mþ/p  Mice Separated by Gender
P1 – P8 indicate the corresponding postnatal days. N is the number of
mice investigated from each genotype. Mean is the average mouse
weight per category in grams. Statistically signiﬁcant differences (p ,
0.05) are indicated in bold.
Found at doi:10.1371/journal.pgen.0030235.st002 (76 KB DOC).
Table S3. Number of Embryos/Pups from Several PWScr
mþ/p  and
PWScr
m /pþ Male Mice
Twenty-nine crosses between PWScr
mþ/p  males and wild type BALB/c
females resulted in 230 embryos/pups. Among those 106 were
identiﬁed as PWScr
mþ/pþ, 121 as PWScr
mþ/p  and 3 were not genotyped.
We have performed 12 crosses between PWScr
m /pþ males and wild
Table 1. C0t, DC0t, DDC0t and N-Fold Values for mRNA Levels from the PWS/AS Locus Obtained with Real-Time PCR
Gene Genotype C0t DC0t DDC0t2
 DDC0t (N-Fold)
Frat3 PWScr
mþ/p  40.09 6 0.43 21.00 6 0.25 0.88 6 0.99 0.54 (0.27 – 1.08)
PWScr
mþ/pþ 40.68 6 1.75 21.88 6 1.67
Mkrn PWScr
mþ/p  25.15 6 1.20 4.27 6 2.15 0.79 6 1.26 0.58 (0.24 – 1.38)
PWScr
mþ/pþ 25.14 6 0.68 5.06 6 0.40
Magel2 PWScr
mþ/p  26.39 6 1.59 5.51 6 2.59 0.69 6 1.56 0.62 (0.21 – 1.83)
PWScr
mþ/pþ 26.27 6 0.51 6.20 6 0.77
Necdin PWScr
mþ/p  23.17 6 0.34 2.29 6 0.68 0.63 6 0.49 0.65 (0.46 – 0.91)
PWScr
mþ/pþ 22.99 6 0.19 2.91 6 0.50
Snrpn PWScr
mþ/p  21.72 6 0.18 0.84 6 0.89 0.44 6 0.66 0.74 (0.47 – 1.17)
PWScr
mþ/pþ 21.35 6 0.43 1.28 6 0.72
Ube3a PWScr
mþ/p  25.57 6 0.48 4.68 6 0.46 0.68 6 0.43 0.63 (0.46 – 0.84)
PWScr
mþ/pþ 25.44 6 0.38 5.36 6 0.59
Atp10a PWScr
mþ/p  30.68 6 0.27 9.80 6 0.87 0.48 6 0.64 0.72 (0.46 – 1.12)
PWScr
mþ/pþ 30.35 6 0.47 10.28 6 0.68
For each mRNA tested at least three independent animals from the same family were analyzed in triplicate. Real-time PCR was performed on an Applied Biosystems platform, using the
manufacturer’s protocol. The amplified regions correspond to the following Applied Biosystems catalog numbers: Necdin Mm02524479_s1; Snrpn Mm01310473_g1; Magel2
Mm0044026_s1; Frat3 Mm00844053_s1; Mkrn3 Mm00844003_s1; Ube3a Mm00839910_m1; Atp10a Mm00437724_m1. As a reference, mRNA of b-Actin (Mm00607939_s1) was used. Data
are expressed as means6SD.
doi:10.1371/journal.pgen.0030235.t001
Figure 6. Expression of snoRNAs and Ipw Transcripts in PWScr-Deleted Mice
(A) Expression analysis of snoRNAs from the PWS locus. 5.8S rRNA was probed as RNA loading control. Mouse genotypes are indicated (see Figure 5).
(B) Northern blot analysis of Ipw transcripts. Ethidium bromide-stained RNA gels (prior to blotting) are shown as RNA loading controls. RNA size markers
are identical to those in Figure 5.
doi:10.1371/journal.pgen.0030235.g006
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Elimination of MBII-85 snoRNA Gene Cluster in Micetype BALB/c females and obtained 100 embryos/pups. Fifty were
identiﬁed as PWScr
mþ/pþ,4 8a sPWScr
mþ/p  and 2 were not genotyped.
Found at doi:10.1371/journal.pgen.0030235.st003 (63 KB DOC).
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